ArticleMolecular therapy. Oncology2024

Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.

Antonio J Montero-Hidalgo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.